Nanoviricides Inc (NNVC)
1.15
+0.01
(+0.88%)
USD |
NYAM |
Apr 24, 16:00
1.13
-0.02
(-1.74%)
After-Hours: 20:00
Nanoviricides Cash from Operations (TTM): -6.127M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.127M |
| September 30, 2023 | -5.809M |
| June 30, 2023 | -5.670M |
| March 31, 2023 | -5.569M |
| December 31, 2022 | -5.486M |
| September 30, 2022 | -6.200M |
| June 30, 2022 | -5.891M |
| March 31, 2022 | -6.721M |
| December 31, 2021 | -6.501M |
| September 30, 2021 | -6.702M |
| June 30, 2021 | -8.214M |
| March 31, 2021 | -7.694M |
| December 31, 2020 | -8.657M |
| September 30, 2020 | -7.468M |
| June 30, 2020 | -6.666M |
| March 31, 2020 | -6.629M |
| December 31, 2019 | -6.242M |
| September 30, 2019 | -7.275M |
| June 30, 2019 | -6.803M |
| March 31, 2019 | -8.650M |
| December 31, 2018 | -7.936M |
| September 30, 2018 | -7.181M |
| June 30, 2018 | -7.776M |
| March 31, 2018 | -5.266M |
| December 31, 2017 | -6.022M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.230M |
| June 30, 2017 | -7.898M |
| March 31, 2017 | -8.271M |
| December 31, 2016 | -8.799M |
| September 30, 2016 | -7.400M |
| June 30, 2016 | -6.829M |
| March 31, 2016 | -6.703M |
| December 31, 2015 | -6.211M |
| September 30, 2015 | -6.170M |
| June 30, 2015 | -6.212M |
| March 31, 2015 | -5.912M |
| December 31, 2014 | -5.684M |
| September 30, 2014 | -6.705M |
| June 30, 2014 | -6.334M |
| March 31, 2014 | -6.750M |
| December 31, 2013 | -6.598M |
| September 30, 2013 | -5.777M |
| June 30, 2013 | -5.798M |
| March 31, 2013 | -5.322M |
| December 31, 2012 | -5.033M |
| September 30, 2012 | -4.887M |
| June 30, 2012 | -4.218M |
| March 31, 2012 | -4.162M |
| December 31, 2011 | -3.962M |
| September 30, 2011 | -3.735M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-8.657M
Minimum
Dec 2020
-5.486M
Maximum
Dec 2022
-6.649M
Average
-6.629M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
| Gilead Sciences Inc | 8.006B |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |